| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 10 | |
| #2 | WIPO (World Intellectual Property Organization) | 3 | |
| #3 | Canada | 2 | |
| #4 | China | 2 | |
| #5 | EPO (European Patent Office) | 2 | |
| #6 | Hong Kong | 2 | |
| #7 | Australia | 1 | |
| #8 | Brazil | 1 | |
| #9 | Israel | 1 | |
| #10 | Japan | 1 | |
| #11 | Republic of Korea | 1 | |
| #12 | Mexico | 1 | |
| #13 | Singapore | 1 | |
| #14 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Kerns William D | 25 |
| #2 | Fogel Barry S | 25 |
| #3 | Fong Kei-Lai | 23 |
| #4 | Lin Edward | 14 |
| #5 | Chow San-Laung | 14 |
| #6 | Wong David | 14 |
| #7 | William D Kerns | 3 |
| #8 | Barry S Fogel | 3 |
| #9 | Edward Lin | 2 |
| #10 | David Wong | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020206107A1 | Formulations | |
| CN105431144A | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
| US2013224292A1 | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
| AU2012345659A1 | Acamprosate formulations, methods of using the same, and combinations comprising the same |